COVID-19 Series

Nov
23

When the Going Gets Tough, the Tough Keep Going: Impact of the COVID-19 Pandemic on Hepatitis C and STI Testing and Care

Program Description The IAS–USA COVID-19 Dialogues bring together leading experts to discuss what the data and research are telling us about the basic science, public health, and clinical aspects of the disease and the consequences of the pandemic. The Dialogue series is intended for healthcare clinicians and researchers, including infectious disease and HIV specialists. The (more…)

DETAIL
Jan
4

Update on COVID-19 Vaccines

Program Description The COVID-19 pandemic has created an urgent need for reliable scientific information. Our understanding of SARS-CoV-2 and COVID-19 disease changes almost daily. Unfortunately, there are also misunderstandings, miscommunications, and controversies. In response, the IAS−USA has created a program that will bring together leading experts to discuss the latest science regarding COVID-19 and what (more…)

DETAIL
Jan
29

Update on SARS-CoV-2 Variants, the Status of Vaccine Development, and Decreasing the Case Rate–What Does it Mean?

Program Description The IAS–USA COVID-19 Dialogues bring together leading experts to discuss what the data and research are telling us about the basic science, public health, and clinical aspects of the disease and the consequences of the pandemic. The Dialogues are intended for healthcare clinicians and researchers. This dialogue will be a continued discussion of (more…)

DETAIL
Feb
10

The Latest on “COVID-19 Meets HIV”: Variants, Vaccines, Health Disparities, and Other Fast-Evolving Issues

Program Description The IAS–USA COVID-19 Dialogues bring together leading experts to discuss what the data and research are telling us about the basic science, public health, and clinical aspects of the disease and the consequences of the pandemic. The Dialogues are intended for healthcare clinicians and researchers. Drs Wendy Armstrong and Carlos del Rio, of (more…)

DETAIL
Apr
13

Update on Early Treatment of COVID-19

Program Description The IAS–USA COVID-19 Dialogues bring together leading experts to discuss what the data and research are telling us about the basic science, public health, and clinical aspects of the disease and the consequences of the pandemic. The Dialogues are intended for healthcare clinicians and researchers.   Sign Up Please use the following link (more…)

DETAIL
Jun
1

Up to Date on COVID-19: Expert Discussion

Program Description The IAS–USA COVID-19 Dialogues bring together leading experts to discuss what the data and research are telling us about the basic science, public health, and clinical aspects of the disease and the consequences of the pandemic. The Dialogues are intended for healthcare clinicians and researchers. Drs George Rutherford and Paul A. Volberding, from (more…)

DETAIL
Jun
18

SARS-CoV-2 Variants: Where Did They Come From and Where Are They Going

Program Description In this Dialogue, Dr Michael S. Saag will speak with Dr Penny Moore from the University of the Witwatersrand in South Africa. Dr Moore and colleagues were among the first to report the SARS-CoV-2 501Y.V2 (referred as B.1.351 and now the Beta variant) in South Africa and how it could escape antibody neutralization. (more…)

DETAIL
Oct
22

Update on COVID-19 in People Who Are Immunocompromised, Waning Immunity, Breakthrough Infection, and Booster Shots

Program Description The IAS–USA COVID-19 Dialogues bring together leading experts to discuss what the data and research are telling us about the basic science, public health, and clinical aspects of COVID-19 and the consequences of the pandemic. This Dialogue will provide an update on COVID-19 in people who are immunocompromised, including people with HIV. Additionally, (more…)

DETAIL
Dec
3

The Latest on the Omicron Variant, Therapeutics, and COVID-19 in People Who Are Immunocompromised

Program Description The IAS–USA COVID-19 Dialogues bring together leading experts to discuss what the data and research are telling us about the basic science, public health, and clinical aspects of COVID-19 and the consequences of the pandemic. This Dialogue will be a continued discussion of the October 22nd Dialogue regarding an update on COVID-19 in (more…)

DETAIL
Feb
4

Latest Update on COVID-19 Vaccines and Scientific Leaders’ Perspectives on When Can We Be “Normal” and Are We at a Pandemic Inflection Point?

Program Description The IAS–USA COVID-19 Dialogues bring together leading experts to discuss what the data and research are telling us about the basic science, public health, and clinical aspects of COVID-19 and the consequences of the pandemic. This Dialogue will provide a discussion on the latest issues regarding COVID-19 vaccines, particularly the immunization of children, (more…)

DETAIL